these new analogs were found to be markedly superior to methotrexate against four of five ascites tumors ( l1210 leukemia , sarcoma 180 , ehrlich carcinoma and tapper carcinosarcoma ) and against four of five solid tumors ( s180 , tapper carcinosarcoma , e0771 mammary adenocarcinoma , lewis lung carcinoma , and t241 sarcoma ) .
C0007125
ascites tumors
C0007097
carcinoma